Goldman Sachs
OPK icon

Goldman Sachs’s Opko Health OPK Stock Holding History

Goldman Sachs’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-25,700
Closed -$77K – 5362
2018
Q4 		$77K Hold
25,700
– – ﹤0.01% 5043
2018
Q3 		$89K Hold
25,700
– – ﹤0.01% 5173
2018
Q2 		$121K Hold
25,700
– – ﹤0.01% 5157
2018
Q1 		$81K Sell
25,700
-30,000
-54% -$121K ﹤0.01% 5351
2017
Q4 		$273K Sell
55,700
-76,300
-58% -$443K ﹤0.01% 5232
2017
Q3 		$906K Buy
132,000
+85,300
+183% +$538K ﹤0.01% 4658
2017
Q2 		$307K Sell
46,700
-3,700
-7% -$25.9K ﹤0.01% 5484
2017
Q1 		$403K Sell
50,400
-52,800
-51% -$445K ﹤0.01% 5219
2016
Q4 		$960K Sell
103,200
-80,600
-44% -$834K ﹤0.01% 4495
2016
Q3 		$1.95M Buy
183,800
+109,700
+148% +$1.09M ﹤0.01% 3857
2016
Q2 		$692K Sell
74,100
-168,000
-69% -$1.71M ﹤0.01% 4543
2016
Q1 		$2.52M Sell
242,100
-43,300
-15% -$396K ﹤0.01% 3279
2015
Q4 		$2.87M Buy
285,400
+52,300
+22% +$524K ﹤0.01% 3317
2015
Q3 		$1.96M Buy
233,100
+156,400
+204% +$2.07M ﹤0.01% 3812
2015
Q2 		$1.23M Sell
76,700
-58,400
-43% -$908K ﹤0.01% 4337
2015
Q1 		$1.91M Sell
135,100
-285,900
-68% -$3.72M ﹤0.01% 3820
2014
Q4 		$4.21M Buy
421,000
+13,800
+3% +$118K ﹤0.01% 3165
2014
Q3 		$3.46M Sell
407,200
-243,100
-37% -$2.14M ﹤0.01% 3381
2014
Q2 		$5.75M Buy
650,300
+174,600
+37% +$1.52M ﹤0.01% 2882
2014
Q1 		$4.43M Sell
475,700
-18,700
-4% -$164K ﹤0.01% 3162
2013
Q4 		$4.17M Buy
494,400
+345,600
+232% +$3.49M ﹤0.01% 3280
2013
Q3 		$1.31M Buy
+148,800
New +$1.19M ﹤0.01% 4341

Other funds holding OPK

Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Highbridge Capital Management
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Goldman Sachs's OPK Position: Q2 2026 in Review

Goldman Sachs reduced its Opko Health (OPK) stake by 8.3% in Q2 2026, selling an estimated $816K and leaving 7,035,492 shares worth $10.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3184.

Goldman Sachs first reported a position in OPK in Q2 2013 and has held it in 53 quarters since. The position peaked at $62.5M in Q1 2015. 222 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

  • Goldman Sachs held 7,035,492 shares of Opko Health worth $10.6M as of Q2 2026.
  • Goldman Sachs sold 639,534 Opko Health shares in Q2 2026, an estimated $816K.
  • Opko Health made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3184 holding.
  • Goldman Sachs first reported a position in Opko Health in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's Opko Health position peaked at $62.5M in Q1 2015.
  • 222 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.